A vaccine against HTLV-1 HBZ makes sense
Copyright policy ) Renaud, Mahieux;
A vaccine against HTLV-1 HBZ makes sense
In this issue of Blood, Sugata et al report that vaccination against human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper (bZIP) factor (HBZ) could be used for immunotherapy in adult T-cell leukemia-lymphoma (ATL) patients.
Human T-lymphotropic virus 1, Vaccines, Synthetic, Viral Proteins, Basic-Leucine Zipper Transcription Factors, Animals, Humans, Leukemia-Lymphoma, Adult T-Cell, Gene Products, tax, T-Lymphocytes, Cytotoxic
Human T-lymphotropic virus 1, Vaccines, Synthetic, Viral Proteins, Basic-Leucine Zipper Transcription Factors, Animals, Humans, Leukemia-Lymphoma, Adult T-Cell, Gene Products, tax, T-Lymphocytes, Cytotoxic
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).18 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
citations
Citations provided by BIP!
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
Citations provided by BIP!popularityPopularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
Popularity provided by BIP! 18
Average
Average
Top 10%
bronze
